Christine Ann Miller

President and Chief Executive Officer at Melinta Therapeutics

Summary

Christine Miller is a dynamic professional with a diverse background in pharmaceuticals, spanning leadership roles in growth strategies, product launches, R&D, and supply chain operations.
With a strong educational foundation including an MBA, a Master's in Technology Management, and a BS in Chemical Engineering, Christine has honed her skills and expertise over the years.
Her career began at Merck as a Chemical Engineer before progressing to key positions at Watson Pharmaceuticals, Allergan/Actavis, and Sandoz, where she spearheaded international and domestic growth through diverse pharmaceutical portfolios.
Christine's strategic acumen is evident in her roles such as President at Melinta Therapeutics, Global Head of Portfolio at Sandoz, and Executive Director at Allergan, where she oversaw product optimization, launch management, and operational excellence.
Her focus on mission, vision, communication, engagement, and execution has been instrumental in her career, driving success in areas like generic and biosimilar medicines, product launches, and R&D operations.
Through articulating clear strategies, inspiring teams, and ensuring operational excellence, Christine has consistently delivered results and guided organizations towards achieving their goals.
Christine's passion for helping people live better lives shines through her work, demonstrating a commitment to making a positive impact in the pharmaceutical industry and beyond.